BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2021 9:38:39 AM | Browse: 353 | Download: 583
 |
Received |
|
2021-04-28 08:20 |
|
Peer-Review Started |
|
2021-04-28 08:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-16 05:51 |
|
Revised |
|
2021-07-28 17:09 |
|
Second Decision |
|
2021-11-22 03:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-11-25 02:49 |
|
Articles in Press |
|
2021-11-25 02:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-02 01:30 |
|
Publish the Manuscript Online |
|
2021-12-24 09:38 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
María Sereno, Oliver Higuera, Patricia Cruz Castellanos, Sandra Falagan, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes and Felipe Couñago |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
María Sereno, MD, PhD, Consultant Physician-Scientist, Medical Oncology Department, Hospital Universitario Infanta Sofía, Paseo Europa 34, ES-28702 Madrid, Spain, San Sebastián de los Reyes 28702, Madrid, Spain. mariasereno75@gmail.com |
| Key Words |
Immunotherapy combinations; Anti- programmed cell death protein; Anti-programmed cell death ligand 1; anti-TIGIT; anti-CTLA-4; Combo; Non-small cell lung cancer |
| Core Tip |
This review presents the results of the main articles reporting on immunotherapy combinations, with or without chemotherapy, focusing principally on efficacy and toxicity data. The convenience of adding shorter chemotherapy regimens vs the standard 4-cycle regimens to immunotherapy doublets is discussed. |
| Publish Date |
2021-12-24 09:38 |
| Citation |
Sereno M, Higuera O, Cruz Castellanos P, Falagan S, Mielgo-Rubio X, Trujillo-Reyes JC, Couñago F. Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer. World J Clin Oncol 2021; 12(12): 1182-1192 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i12/1182.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i12.1182 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
